Skip to content
Shibolet & Co. Law Firm

Shibolet & Co. Law Firm

  • Our story
    • Our story
    • Client Business Development
    • Recognition
    • Corporate Social Responsibility (CSR)
    • Art Collection
  • Meet the Team
    • Legal Team
    • Operations Team
  • Expertise
  • Media Center
    • Media Center
    • Client Updates
    • Professional Articles
    • Podcast
    • Webinar
  • Life at Shibolet
    • Life at Shibolet
    • Interns at Shibolet
  • Shibolet Alumni
  • Subscribe
  • English
  • עברית
  • 中文 (中国)
  • Italiano
  • 日本語
  • Español
  • العربية
  • Our story
    • Our story
    • Client Business Development
    • Recognition
    • Corporate Social Responsibility (CSR)
    • Art Collection
  • Meet the Team
    • Legal Team
    • Operations Team
  • Expertise
  • Media Center
    • Media Center
    • Client Updates
    • Professional Articles
    • Podcast
    • Webinar
  • Life at Shibolet
    • Life at Shibolet
    • Interns at Shibolet
  • Shibolet Alumni
  • Subscribe
  • English
  • עברית
  • 中文 (中国)
  • Italiano
  • 日本語
  • Español
  • العربية
Home » Capital Markets » Page 3

Capital Markets

Capital Markets
Representation of Compugen on the completion of a $20M dollar PIPE by American bio-pharma company
January 26, 2022

Representation of Compugen on the completion of a $20M dollar PIPE by American bio-pharma company

Read More: Representation of Compugen on the completion of a $20M dollar PIPE by American bio-pharma company
Capital Markets
Representation of Camtek Ltd. in a US$ 200 million private offering to qualified institutional buyers on the Nasdaq
January 25, 2022

Representation of Camtek Ltd. in a US$ 200 million private offering to qualified institutional buyers […]

Read More: Representation of Camtek Ltd. in a US$ 200 million private offering to qualified institutional buyers on the Nasdaq
Capital Markets
REPRESENTATION OF EL AL IN AN AGREEMENT WITH THE MINISTRY OF FINANCE FOR $ 52 MILLION IN GRANTS
January 24, 2022

REPRESENTATION OF EL AL IN AN AGREEMENT WITH THE MINISTRY OF FINANCE FOR $ 52 […]

Read More: REPRESENTATION OF EL AL IN AN AGREEMENT WITH THE MINISTRY OF FINANCE FOR $ 52 MILLION IN GRANTS
Capital Markets
REPRESENTATION OF EPITOMEE MEDICAL LTD ON THEIR SUCCESSFUL 162 MILLION NIS IPO ON THE TEL AVIV STOCK EXCHANGE FOR AN EVALUATION OF 632 MILLION NIS
December 16, 2021

REPRESENTATION OF EPITOMEE MEDICAL LTD ON THEIR SUCCESSFUL 162 MILLION NIS IPO ON THE TEL […]

Read More: REPRESENTATION OF EPITOMEE MEDICAL LTD ON THEIR SUCCESSFUL 162 MILLION NIS IPO ON THE TEL AVIV STOCK EXCHANGE FOR AN EVALUATION OF 632 MILLION NIS
Capital Markets
Representation of Camtek Ltd in raising a total of USD 200 Million
November 24, 2021

Representation of Camtek Ltd in raising a total of USD 200 Million

Read More: Representation of Camtek Ltd in raising a total of USD 200 Million
Capital Markets
Representation of Compugen on the completion of a $20M dollar PIPE
November 10, 2021

Representation of Compugen on the completion of a $20M dollar PIPE

Read More: Representation of Compugen on the completion of a $20M dollar PIPE
Capital Markets
TopGum GOES PUBLIC
August 15, 2021

TopGum GOES PUBLIC

Read More: TopGum GOES PUBLIC
Capital Markets
Representation of top-tier institutional investors in an USD $150 million PIPE transaction
June 27, 2021

Representation of top-tier institutional investors in an USD $150 million PIPE transaction

Read More: Representation of top-tier institutional investors in an USD $150 million PIPE transaction
Capital Markets
Representation of Pulsenmore in a successful IPO, raising US$ 40 million at a US$ 190 million dollar company valuation
June 09, 2021

Representation of Pulsenmore in a successful IPO, raising US$ 40 million at a US$ 190 […]

Read More: Representation of Pulsenmore in a successful IPO, raising US$ 40 million at a US$ 190 million dollar company valuation
Capital Markets
Inrom group buying the minority shares in nirlat
March 24, 2021

Inrom group buying the minority shares in nirlat

Read More: Inrom group buying the minority shares in nirlat
Capital Markets
Representation of El Al in a public offering of options with a value of 250 million NIS
February 22, 2021

Representation of El Al in a public offering of options with a value of 250 […]

Read More: Representation of El Al in a public offering of options with a value of 250 million NIS
Capital Markets
HOME BIOGAS COMPLETES IPO AT APPROX. NIS 310 MILLION VALUE
January 31, 2021

HOME BIOGAS COMPLETES IPO AT APPROX. NIS 310 MILLION VALUE

Read More: HOME BIOGAS COMPLETES IPO AT APPROX. NIS 310 MILLION VALUE

Posts pagination

Previous 1 2 3 4 5 Next

Stay updated

Subscribe
  • Our story
  • Team
  • Expertise
  • Media
  • Life at Shibolet
  • Alumni
  • Terms of Use
  • Privacy Policy
  • Facebook
  • LinkedIn
  • Mail

Yitzhak Sadeh 4 Tel Aviv, Israel 6777504 +972-3-307-5000
© 2026 Shibolet Law Firm

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT